Skip to main content

Wisdom

Travel During COVID-19 Pandemic

Jan 18, 2021

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Read Article

2020 Rheumatology Year in Review

Jan 14, 2021

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article

Delays in Diagnosis of Axial Spondyloarthritis

Jan 12, 2021

The diagnosis of axial spondyloarthritis (and anklylosing spondylitis) (axSpA) is often delayed and usually not diagnosed by rheumatologists; a recent metanalysis shows that longer delays were attributable to lower education levels, younger age at onset and absence of extra-articular

Read Article

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Jan 08, 2021

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.

Read Article

Telemedicine Less Utilized in the South and Urban Areas

Jan 04, 2021

MMWR has reported on a July 2020 survey study from 1,009 Health Resources and Services Administration–funded health centers showing that urban Health centers were more likely to provide virtual visits than those in rural areas.



Telehealth has expanded healthcare access, especially in

Read Article

Best of 2020: New EULAR/ACR Classification Criteria for SLE

Dec 29, 2020

The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) have jointly developed new classification criteria for systemic lupus erythematosus (SLE); prompted by the need for criteria that were both highly sensitive and specific. The net result is improved

Read Article

Best of 2020: Infusions in the Time of Coronavirus

Dec 28, 2020

After years of bemoaning the challenges of telemedicine, our rheumatology clinic transition entirely to a remote clinic in the space of a week. One of the few good things to come out of this crisis is that we may learn that in-person visits are not as critical as we thought, which may in turn

Read Article

ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations)

CDC/MMWR
Dec 18, 2020

Following the FDA issuance of an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the prevention of COVID-19 in persons aged ≥16 years. 



The PfizerCOVID-19 vaccine (BNT162b2

Read Article

Encouraging Rheumatology Fellowship Match for 2021

JJ Cush and ACR Press Release
Dec 18, 2020

The results of the National Residents Matching Program (NRMP) match in rheumatology are out and show that rheumatology fellowship was both competitive and highly sought after.



Rheumatology was among the most competitive of subspecialties, that included Allergy and Immunology,

Read Article
What a great interview with @IreneBlancoMD regarding equity and inclusion in rheumatology. She is amazing! Such an important topic for all of us! #ACR20 @rheumnow https://t.co/cmRfXVGGDJ

Dr. Rachel Tate uptoTate ( View Tweet)

Nov 09, 2020
A new (better) approach to #rheumatic disease treatment has to include wellness, lifestyle, and beyond. And this includes #empathy, says @LCalabreseDO at #ACR20. https://t.co/paE1Io6uvC
CreakyJoints.org CreakyJoints ( View Tweet)
Nov 09, 2020
What are you doing at 12pm today on this #ACR20 Monday? I will be listening to @LCalabreseDO discuss the importance of #empathy in rheumatology @HealioRheum @RheumNow https://t.co/E1cH39z64p
Cassandra Calabrese CCalabreseDO ( View Tweet)
Nov 09, 2020
@CCalabreseDO @MamutMary and I discuss work and work/life balance at #ACR20 https://t.co/mlfDgK4zvz @RheumNow

Dr. Rachel Tate uptoTate ( View Tweet)

Nov 08, 2020

Check Out the Virtual ACR Playbook

Nov 04, 2020

If you need a plan for this weekend's ACR meeting, check out and download our latest, "Virtual ACR 2020 Playbook". The playbook covers: setting virtual learning goals, sessions you probably shouldn't miss, how to still have peer interactions, what to do if you only have time to "dabble' - and

Read Article
This is the best blog I've ever written. https://t.co/u2kHUD4sSw

Dr. John Cush RheumNow ( View Tweet)

Oct 30, 2020

Are Rheums Attending ACR 2020?

Oct 30, 2020

ACR 2020 (aka ACR Convergence) is just around the corner, with the opening ceremonies and lecture starting Thursday, November 5th; followed by the full meeting beginning the next morning, Friday November 6th. 

Read Article

High Burnout Rates Among Rheumatologists

Oct 22, 2020

Bergman and colleagues have studied a large cohort of US rheumatologists and found that nearly half meet at least one criterion defining "burnout" among physicians.



While attending the annual rheumatology review meeting in 2019 (Rheumatology Winter Clinical Symposium) 128

Read Article

TNF Inhibitors or non-TNF Biologics - First Best Choice?

Oct 18, 2020

Prospective observational findings from the CORRONA registry of rheumatoid arthritis (RA) patients compared clinical outcomes between initial aggressive therapy using either a tumour necrosis factor inhibitor (TNFi) or a non-TNFi (biological disease-modifying antirheumatic drugs (bDMARDs) and

Read Article

COVID Transmission from Young to Old

Oct 13, 2020

The CDC has analyzed temporal trends in percent positivity by age group in COVID-19 hotspot counties before and after their identification as hotspots. Among 767 hotspot counties identified during June and July 2020, early increases in the percent positivity among persons aged ≤24 years were

Read Article

2020 Nobel Prize in Medicine Goes to the Discovery of Hepatitis C

Oct 05, 2020

The Nobel Assembly at Karolinska Institutet has awarded the 2020 Nobel Prize in Physiology or Medicine jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus. These three scientists made a decisive contribution to the fight against blood-borne

Read Article

Defining Difficult Rheumatoid Arthritis

Oct 01, 2020

‘Difficult-to-treat RA’ is an oft-used term that carries various clinical qualities and therapeutic disappointments. A EULAR Task Force was established to develop recommendations for the management of difficult-to-treat rheumatoid arthritis and as a first step, have put forth their definition of

Read Article
Swedish registry comparison of 541 PsA 40944 non-PsA pregnancies between 1997-2014, shows PsA pregnancies had increased risks for preterm birth (adj OR 1.63) and caesarean deliveries (OR 1.47), but no increased risks for pre-eclampsia, stillbirth https://t.co/3Udpjh

Dr. John Cush RheumNow ( View Tweet)

Sep 13, 2020
117 pregnancies exposed to biologics were compared to 585 pregnancies not exposed to biologics; 6% of newborns had ≥1 congenital anomalies. No significant association between biologic exposure and congenital anomalies (HR 1.06; 95%CI 0.46-2.47) was seen.

Dr. John Cush RheumNow ( View Tweet)

Sep 11, 2020
QD Videos from RheumNow Live. "I wanna get pregnant" (a controlled RA patient on tocilizumab) https://t.co/vfLgQPrl98

Dr. John Cush RheumNow ( View Tweet)

Sep 09, 2020
×